NASDAQ:VERU - Veru Stock Price, Forecast & News

Veru trades on the NASDAQ under the ticker symbol "VERU."

Veru Inc (NASDAQ:VERU) released its quarterly earnings results on Thursday, December, 12th. The company reported ($0.05) earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.05). The firm had revenue of $8.73 million for the quarter, compared to analysts' expectations of $9.26 million. Veru had a negative net margin of 37.79% and a negative return on equity of 34.96%. View Veru's Earnings History.

Veru is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Veru.

6 Wall Street analysts have issued 1-year target prices for Veru's shares. Their forecasts range from $5.00 to $12.00. On average, they expect Veru's share price to reach $6.67 in the next year. This suggests a possible upside of 96.1% from the stock's current price. View Analyst Price Targets for Veru.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veru in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Veru.

News stories about VERU stock have trended very negative on Tuesday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Veru earned a coverage optimism score of -3.8 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Veru.

Veru saw a increase in short interest during the month of January. As of January 15th, there was short interest totalling 114,300 shares, an increase of 32.1% from the December 31st total of 86,500 shares. Based on an average daily volume of 253,000 shares, the short-interest ratio is presently 0.5 days. Approximately 0.2% of the company's stock are short sold. View Veru's Current Options Chain.

Some companies that are related to Veru include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Avon Products (AVP), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Nu Skin Enterprises (NUS), USANA Health Sciences (USNA), Revlon (REV), Medifast (MED) and Nature's Sunshine Products (NATR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Veru investors own include Corbus Pharmaceuticals (CRBP), NovaBay Pharmaceuticals (NBY), Opko Health (OPK), Genocea Biosciences (GNCA), Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), Verastem (VSTM), Agile Therapeutics (AGRX), Biocept (BIOC) and Idera Pharmaceuticals (IDRA).

Veru's stock is owned by many different of institutional and retail investors. Top institutional investors include Wedge Capital Management L L P NC (0.45%) and Alpine Global Management LLC (0.04%). Company insiders that own Veru stock include Harry Fisch, Jesus Socorro, K Gary Barnette, Michele Greco and Mitchell Shuster Steiner. View Institutional Ownership Trends for Veru.

VERU stock was acquired by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC and Alpine Global Management LLC. Company insiders that have bought Veru stock in the last two years include Harry Fisch, Jesus Socorro, K Gary Barnette, Michele Greco and Mitchell Shuster Steiner. View Insider Buying and Selling for Veru.

Shares of VERU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VERU stock can currently be purchased for approximately $3.40.

Veru has a market capitalization of $221.14 million and generates $31.80 million in revenue each year. The company earns $-12,020,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis. Veru employs 171 workers across the globe.View Additional Information About Veru.

The official website for Veru is http://www.veruhealthcare.com/.

Veru's mailing address is 48 NW 25th Street Suite 102, Miami FL, 33127. The company can be reached via phone at 305-509-6897 or via email at [email protected]